Who
Pierre Thadee Victor Kemula
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, AgomAb Therapeutics NV.
In numbers
- Trades disclosed
- 3
- Buys
- 1
- Sells
- 0
- Bought
- $86K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 6 Oct 2026
- Last trade
- 6 Oct 2026
- Last filed
- 7 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Oct 2026filed 7 Oct 2026 | AGMB AgomAb Therapeutics NVBiotechnology | SEC FORM 4 Bought | $26K3,000 at $8.67 | filing |
| 6 Oct 2026filed 7 Oct 2026 | AGMB AgomAb Therapeutics NVBiotechnology | SEC FORM 4 Bought | $43K5,000 at $8.57 | filing |
| 6 Oct 2026filed 7 Oct 2026 | AGMB AgomAb Therapeutics NVBiotechnology | SEC FORM 4 Bought | $17K2,000 at $8.54 | filing |
News
No headline names them, or the companies they trade most, lately.